22nd Century Group, Inc., headquartered in Williamsville, New York, specializes in agricultural biotechnology focusing on tobacco harm reduction and plant science innovations using genetic engineering and molecular breeding. The company, which went public in 2006, operates primarily in the tobacco industry, producing reduced nicotine cigarettes and providing contract manufacturing for other brands.
22nd Century Group (XXII) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, 22nd Century Group's actual EPS was -$0.36, beating the estimate of -$5.08 per share, resulting in a 92.91% surprise.
📡️ Consumer Staples
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
